Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

38.95
Delayed Data
As of 3:59pm ET
 -0.25 / -0.64%
Today’s Change
29.95
Today|||52-Week Range
68.32
+20.59%
Year-to-Date
Baron Funds Comments on PaciraPharmaceuticals
Jan 18 / GuruFocus News - Paid Partner Content
Investing in Earlier Stage Small Cap Growth Companies - Baron Discovery Fund
Jan 18 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close39.20
Today’s open39.30
Day’s range38.78 - 39.80
Volume424,219
Average volume (3 months)997,666
Market cap$1.5B
Dividend yield--
Data as of 3:59pm ET, 01/24/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-42.89%
Earnings growth (next 5 years)+70.00%
Revenue growth (last year)+25.97%
P/E ratioNM
Price/Sales12.74
Price/Book6.61

Competitors

 Today’s
change
Today’s
% change
FWPForward Pharma A/S-0.28-0.90%
LXRXLexicon Pharmaceutic...+0.26+1.87%
PTLAPortola Pharmaceutic...+0.15+0.60%
TBPHTheravance Biopharma...-1.00-3.33%
Data as of 4:00pm ET, 01/24/2017

Financials

Next reporting dateFebruary 28, 2017
EPS forecast (this quarter)$0.01
Annual revenue (last year)$249.0M
Annual profit (last year)$1.9M
Net profit margin0.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
David M. Stack
President
James S. Scibetta
Corporate headquarters
Parsippany, New Jersey

Forecasts


Search for Jobs